AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome
Fragile X syndrome, the most common form of inherited intellectual disability, is caused by a lack of FMRP, which is the product of the Fmr1 gene. FMRP is an RNA-binding protein and a component of RNA-granules found in the dendrites of neurons. At the synapse, FMRP is involved in regulation of trans...
Main Authors: | Josien Levenga, Shigemi Hayashi, Femke M.S. de Vrij, Sebastiaan K. Koekkoek, Herma C. van der Linde, Ingeborg Nieuwenhuizen, Cheng Song, Ronald A.M. Buijsen, Andreea S. Pop, Baltazar GomezMancilla, David L. Nelson, Rob Willemsen, Fabrizio Gasparini, Ben A. Oostra |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-06-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096999611100043X |
Similar Items
-
The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant <it>FMR1 </it>gene <it>in vitro</it>
by: Tabolacci Elisabetta, et al.
Published: (2012-03-01) -
Rescue of Fmr1KO phenotypes with mGluR5 inhibitors: MRZ-8456 versus AFQ-056
by: Pamela R. Westmark, et al.
Published: (2018-11-01) -
BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy
by: Yun-Yu Chen, et al.
Published: (2021-01-01) -
Novel aspects of transition metal hydride chemistry
by: Guilera, Gemma
Published: (2003) -
Palladium-ruthenium bimetallic cascades
by: Morris, James Alan
Published: (2004)